Thymoma: Results of treatment and role of radiotherapy

✍ Scribed by Marcin Hetnał; Krzysztof Małecki; Magdalena Wolanin; Stanisław Korzeniowski; Tomasz Walasek

• Publisher: Wielkopolskie Centrum Onkologii
• Year: 2010
• Tongue: Polish
• Weight: 275 KB
• Volume: 15
• Category: Article
• ISSN: 1507-1367
• DOI: 10.1016/j.rpor.2010.01.004

✦ Synopsis

Purpose:

The aim of this study is to assess results of treatment, factors influencing prognosis with regard to causes of failure and treatment tolerance in patients with thymoma.

Material and methods:

Between 1966 and 2006, 63 patients with thymoma had been treated at the centre of oncology in krakow. patients were treated by means of different treatment modalities: surgery followed by radiotherapy (52%), radiotherapy alone (13%), chemoradiotherapy alone (15%), surgery followed by chemoradiotherapy (5%), surgery alone (5%) and others.

Results:

The 10-year locoregional recurrence-free survival (lrrfs) was 79%, disease free survival (dfs) was 57% and overall survival (os) was 57%. masaoka stage was the only independent prognostic factor for lrrfs. masaoka stage and method of radiotherapy delivery (higher photon energies), were independent prognostic factors for os. for dfs, the independent prognostic factors were age, type of treatment (favoured surgery followed by radiotherapy or chemoradiotherapy), masaoka stage and year of start of treatment. most common reactions were lung fibrosis in 36% of patients (mainly asymptomatic in most patients), pneumonitis (9%) and oesophagitis (4%).

Conclusions:

Surgery combined with radiotherapy and chemoradiotherapy and modern radiotherapy techniques are correlated with improvement of survival in patients with early stage thymoma.